NO20090322L - 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor - Google Patents

6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor

Info

Publication number
NO20090322L
NO20090322L NO20090322A NO20090322A NO20090322L NO 20090322 L NO20090322 L NO 20090322L NO 20090322 A NO20090322 A NO 20090322A NO 20090322 A NO20090322 A NO 20090322A NO 20090322 L NO20090322 L NO 20090322L
Authority
NO
Norway
Prior art keywords
hiv
inhibitor
agent
compound
integrave
Prior art date
Application number
NO20090322A
Other languages
English (en)
Inventor
Hisashi Shinkai
Hiroshi Kawakami
Hiroshi Nakamura
Motohide Satoh
Hisateru Aramaki
Yuji Matsuzaki
Shuichi Wamaki
Masaki Yamashita
Masafumi Inoue
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of NO20090322L publication Critical patent/NO20090322L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

hvori hvert symbol er som definert i beskrivelsen, eller et farmasøytisk akseptabelt salt derav, eller et solvat derav, og en farmasøytisk sammensetning, et anti-HIV-middel og en HIV-integraseinhibitor som inneholder slik forbindelse. Forbindelsen ifølge oppfinnelsen har en HIV-integraseinhiberingsaktivitet, og er anvendelig som et anti-HIV-middel, eller som et middel for profylakse eller behandling av AIDS. I tillegg, ved den kombinerte anvendelsen med andre anti-HIV-midler slik som en proteaseinhibitor, en revers transkriptaseinhibitor og lignende, kan den være et mer effektivt anti-HIV-middel. På grunn av at den viser integrasespesifikk høyinhiberingsaktivitet, kan forbindelsen være et farmasøytisk middel sikkert for menneskekroppen, som kun forårsaker noen få bivirkninger.
NO20090322A 2006-06-23 2009-01-21 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor NO20090322L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006174331 2006-06-23
JP2006220082 2006-08-11
JP2006274143 2006-10-05
PCT/JP2007/062579 WO2007148780A1 (ja) 2006-06-23 2007-06-22 ６－（複素環置換ベンジル）－４－オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用

Publications (1)

Publication Number Publication Date
NO20090322L true NO20090322L (no) 2009-03-20

Family

ID=38833517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090322A NO20090322L (no) 2006-06-23 2009-01-21 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor

Country Status (19)

Country Link
US (1) US7872004B2 (no)
EP (2) EP2033954A4 (no)
JP (1) JP4038231B1 (no)
KR (1) KR101053811B1 (no)
AR (1) AR061583A1 (no)
AU (1) AU2007262010B2 (no)
BR (1) BRPI0713336A2 (no)
CA (1) CA2653830C (no)
CL (1) CL2007001838A1 (no)
CO (1) CO6150181A2 (no)
IL (1) IL195862A0 (no)
MX (1) MX2009000159A (no)
MY (1) MY144773A (no)
NO (1) NO20090322L (no)
NZ (1) NZ573709A (no)
PE (1) PE20080211A1 (no)
SA (1) SA07280343B1 (no)
TW (1) TW200811153A (no)
WO (1) WO2007148780A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3406596A1 (en) * 2002-11-20 2018-11-28 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
JP5221544B2 (ja) * 2006-09-12 2013-06-26 ギリアード サイエンシーズ， インコーポレイテッド インテグラーゼ阻害剤を調製するためのプロセスおよび中間体
AR068403A1 (es) * 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
WO2011045330A1 (en) 2009-10-13 2011-04-21 Tibotec Pharmaceuticals Macrocyclic integrase inhibitors
RU2567385C2 (ru) 2010-04-02 2015-11-10 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Макроциклические ингибиторы интегразы
AU2012345732B2 (en) 2011-11-30 2016-07-14 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
IN2015DN01688A (no) 2012-08-03 2015-07-03 Gilead Sciences Inc
TWI745900B (zh) 2019-03-22 2021-11-11 美商基利科學股份有限公司 橋鍵聯三環胺甲醯吡啶酮化合物及其醫藥用途
PE20221569A1 (es) 2020-02-24 2022-10-06 Gilead Sciences Inc Compuestos tetraciclicos para el tratamiento de infecciones por vih
ES2968058T3 (es) 2021-01-19 2024-05-07 Gilead Sciences Inc Compuestos de piridotriazina sustituidos y usos de los mismos
TWI843506B (zh) 2022-04-06 2024-05-21 美商基利科學股份有限公司 橋聯三環胺甲醯基吡啶酮化合物及其用途
CN115448866B (zh) * 2022-10-13 2023-11-21 中北大学 一种1-甲基-2,3,4,5-四硝基吡咯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100051A3 (en) * 1997-09-15 2002-08-28 Procter & Gamble Antimicrobial quinolones, their compositions and uses
AU2003236827A1 (en) 2002-07-08 2004-01-23 Coloplast A/S Conduit device
EP3406596A1 (en) 2002-11-20 2018-11-28 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
DE602005023717D1 (de) 2004-03-10 2010-11-04 Usa Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids-related complex (arc)
US7531554B2 (en) * 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
US7745459B2 (en) * 2004-09-21 2010-06-29 Japan Tobacco Inc. Quinolizinone compound and use thereof as HIV integrase inhibitor
WO2006033422A1 (ja) 2004-09-21 2006-03-30 Japan Tobacco Inc. キノリジノン化合物、およびそのｈｉｖインテグラーゼ阻害剤としての利用
JP2006174331A (ja) 2004-12-20 2006-06-29 Fuji Xerox Co Ltd 画像圧縮装置、画像圧縮方法及びそのプログラム
JP2006220082A (ja) 2005-02-10 2006-08-24 Denso Corp 燃料噴射装置
JP4572720B2 (ja) 2005-03-30 2010-11-04 Ｄｉｃ株式会社 水分散型アクリル系樹脂の製造方法、並びにそれにより製造される水分散型アクリル粘着剤組成物及び粘着シート
DE102006005861A1 (de) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III

Also Published As

Publication number Publication date
WO2007148780A1 (ja) 2007-12-27
JP4038231B1 (ja) 2008-01-23
KR101053811B1 (ko) 2011-08-03
EP2033954A1 (en) 2009-03-11
AU2007262010B2 (en) 2011-05-12
KR20090023731A (ko) 2009-03-05
US20080207618A1 (en) 2008-08-28
CL2007001838A1 (es) 2008-02-08
EP2033954A4 (en) 2009-08-12
PE20080211A1 (es) 2008-04-23
BRPI0713336A2 (pt) 2012-11-06
CA2653830C (en) 2011-11-22
TW200811153A (en) 2008-03-01
SA07280343B1 (ar) 2011-01-15
IL195862A0 (en) 2009-09-01
CO6150181A2 (es) 2010-04-20
MY144773A (en) 2011-10-31
MX2009000159A (es) 2009-01-23
US7872004B2 (en) 2011-01-18
EP2368880A1 (en) 2011-09-28
JP2008110960A (ja) 2008-05-15
AR061583A1 (es) 2008-09-03
AU2007262010A1 (en) 2007-12-27
NZ573709A (en) 2011-04-29
CA2653830A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
NO20090322L (no) 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor
TW200510425A (en) Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
MY136173A (en) 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MX2022000563A (es) Derivado de adenosina y composición farmacéutica que lo comprende.
MX2019007262A (es) Compuestos antivirales de bencilamina fosfodiamida.
NO20045152L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
NO20063958L (no) HIV integrase inhibitorer
NO20080913L (no) HIV-revers-transriptaseinhibitorer
EA200970572A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
NO20010743L (no) Antivirale indoloksoacetyl-piperazin-derivater
CA2998646C (en) 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
MA34002B1 (fr) Thérapie antivirale
UA114006C2 (xx) Похідні 5-фенокси-3h-піримідин-4-ону і їхнє застосування як інгібіторів зворотної транскриптази віл
EA200601654A1 (ru) Ингибиторы интегразы вич
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
WO2008010953A3 (en) Pyridinone diketo acids: inhibitors of hiv replication in combination therapy
CL2008003786A1 (es) Compuestos derivados de 1h-pirazolo[3,4-c]piridazinilo, 1h pirazolo[3,4-b]piridinilo, ah-pirazolo[3,4-c]piridinilo e indazolilo, inhibidores no nucleosidicos de la transcriptasa reversa del vih-1(nnrti); composicion fa<rma<ceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por viv, sida o arc.
TW200738700A (en) HIV integrase inhibitors
GEP20156368B (en) Non-nucleoside reverse transcriptase inhibitors
WO2006083553A3 (en) Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
EA201170537A1 (ru) Ингибиторы вич-интегразы
SG155939A1 (en) Phosphoindoles as hiv inhibitors
WO2016086153A3 (en) Use of hsp90 inhibitors for the treatment of hiv infections and aids
WO2007019101A3 (en) Hiv integrase inhibitors
EA202191711A1 (ru) Производные пиримидона в качестве селективных цитотоксических агентов против вич-инфицированных клеток

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application